Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Basic & Clinical Pharmacology & Toxicology
|
October 12, 2013
Anticholinergic drug burden in older people's brain - how well is it measured?
Hege Kersten, Torgeir Bruun Wyller
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
September 17, 2009
[Pharmacotherapy in nursing homes]
Hege Kersten, Sabine Ruths, Torgeir Bruun Wyller
Therapeutic Drug Monitoring
|
October 4, 2013
Association between inherited CYP2D6/2C19 phenotypes and anticholinergic measures in elderly patients using anticholinergic drugs
Hege Kersten, Torgeir B Wyller, Espen Molden
Dementia and Geriatric Cognitive Disorders Extra
|
September 2, 2014
Brief Tests such as the Clock Drawing Test or Cognistat Can Be Useful Predictors of Conversion from MCI to Dementia in the Clinical Assessment of Outpatients
Magnar Nesset, Hege Kersten, Ingun Dina Ulstein
Journal of the American Geriatrics Society
|
March 12, 2011
Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay
Stine Mjåvatn Jakobsen, Hege Kersten, Espen Molden
British Journal of Clinical Pharmacology
|
August 29, 2012
Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes
Hege Kersten, Espen Molden, Tiril Willumsen, et al.
Drugs & Aging
|
April 30, 2020
Prescribed Doses of CYP2D6-Metabolized Drugs and Hemodynamic Responses in Relation to CYP2D6 Genotype Among Older Patients Exposed to Polypharmacy
Rita Romskaug, Torgeir Bruun Wyller, Jørund Straand, et al.
Scandinavian Journal of Urology
|
April 15, 2020
Work status and work ability after radical prostatectomy or active surveillance for prostate cancer
Rasmus Nilsson, Alv A Dahl, Tomm Bernklev, et al.
European Journal of Clinical Pharmacology
|
January 22, 2019
Can screening tools for potentially inappropriate prescriptions in older adults prevent serious adverse drug events?
Marte Sofie Wang-Hansen, Torgeir Bruun Wyller, Lara T Hvidsten, et al.
Plos One
|
January 7, 2022
The association between geriatric treatment and 30-day readmission risk among medical inpatients aged ≥75 years with multimorbidity
Marte Sofie Wang-Hansen, Hege Kersten, Jūratė Šaltytė Benth, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Basic & Clinical Pharmacology & Toxicology
|
October 12, 2013
Anticholinergic drug burden in older people's brain - how well is it measured?
Hege Kersten, Torgeir Bruun Wyller
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
September 17, 2009
[Pharmacotherapy in nursing homes]
Hege Kersten, Sabine Ruths, Torgeir Bruun Wyller
Therapeutic Drug Monitoring
|
October 4, 2013
Association between inherited CYP2D6/2C19 phenotypes and anticholinergic measures in elderly patients using anticholinergic drugs
Hege Kersten, Torgeir B Wyller, Espen Molden
Dementia and Geriatric Cognitive Disorders Extra
|
September 2, 2014
Brief Tests such as the Clock Drawing Test or Cognistat Can Be Useful Predictors of Conversion from MCI to Dementia in the Clinical Assessment of Outpatients
Magnar Nesset, Hege Kersten, Ingun Dina Ulstein
Journal of the American Geriatrics Society
|
March 12, 2011
Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay
Stine Mjåvatn Jakobsen, Hege Kersten, Espen Molden
British Journal of Clinical Pharmacology
|
August 29, 2012
Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes
Hege Kersten, Espen Molden, Tiril Willumsen, et al.
Drugs & Aging
|
April 30, 2020
Prescribed Doses of CYP2D6-Metabolized Drugs and Hemodynamic Responses in Relation to CYP2D6 Genotype Among Older Patients Exposed to Polypharmacy
Rita Romskaug, Torgeir Bruun Wyller, Jørund Straand, et al.
Scandinavian Journal of Urology
|
April 15, 2020
Work status and work ability after radical prostatectomy or active surveillance for prostate cancer
Rasmus Nilsson, Alv A Dahl, Tomm Bernklev, et al.
European Journal of Clinical Pharmacology
|
January 22, 2019
Can screening tools for potentially inappropriate prescriptions in older adults prevent serious adverse drug events?
Marte Sofie Wang-Hansen, Torgeir Bruun Wyller, Lara T Hvidsten, et al.
Plos One
|
January 7, 2022
The association between geriatric treatment and 30-day readmission risk among medical inpatients aged ≥75 years with multimorbidity
Marte Sofie Wang-Hansen, Hege Kersten, Jūratė Šaltytė Benth, et al.
Page
of 4